Total Payments
$1.0M
2024 Payments
$75,034
Companies
55
Transactions
1,211
Medicare Patients
869
Medicare Billing
$1.5M
Payment Breakdown by Category
Other$699,022 (66.9%)
Consulting$243,730 (23.3%)
Travel$73,016 (7.0%)
Food & Beverage$24,953 (2.4%)
Gifts$2,859 (0.3%)
Education$672.68 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $699,022 | 220 | 66.9% |
| Consulting Fee | $243,730 | 63 | 23.3% |
| Travel and Lodging | $73,016 | 185 | 7.0% |
| Food and Beverage | $24,953 | 730 | 2.4% |
| Gift | $2,859 | 1 | 0.3% |
| Education | $672.68 | 12 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $459,757 | 373 | $0 (2024) |
| EMD Serono, Inc. | $244,902 | 268 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $102,800 | 146 | $0 (2023) |
| GENZYME CORPORATION | $62,895 | 72 | $0 (2024) |
| TG Therapeutics, Inc. | $56,832 | 55 | $0 (2024) |
| Genentech USA, Inc. | $46,078 | 64 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $40,173 | 45 | $0 (2022) |
| Novartis Pharma AG | $18,328 | 5 | $0 (2021) |
| Amgen Inc. | $7,744 | 10 | $0 (2024) |
| Celgene Corporation | $1,189 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $75,034 | 78 | EMD Serono, Inc. ($32,822) |
| 2023 | $126,996 | 121 | EMD Serono, Inc. ($63,802) |
| 2022 | $101,990 | 132 | Biogen, Inc. ($79,930) |
| 2021 | $100,931 | 119 | Biogen, Inc. ($72,308) |
| 2020 | $137,110 | 137 | Biogen, Inc. ($79,067) |
| 2019 | $218,948 | 257 | Biogen, Inc. ($103,040) |
| 2018 | $126,470 | 98 | Biogen, Inc. ($65,756) |
| 2017 | $156,773 | 269 | Teva Pharmaceuticals USA, Inc. ($40,126) |
All Payment Transactions
1,211 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $4.42 | General |
| 11/21/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Immunology | ||||||
| 11/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $930.00 | General |
| Category: Immunology | ||||||
| 11/12/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $124.63 | General |
| 10/30/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $6.01 | General |
| 10/23/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $17.61 | General |
| 10/12/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Consulting Fee | Cash or cash equivalent | $5,365.00 | General |
| Category: Immunology | ||||||
| 10/12/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Travel and Lodging | In-kind items and services | $451.62 | General |
| Category: Immunology | ||||||
| 10/12/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Travel and Lodging | In-kind items and services | $280.30 | General |
| Category: Immunology | ||||||
| 10/12/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $125.14 | General |
| Category: Immunology | ||||||
| 10/12/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $80.28 | General |
| Category: Immunology | ||||||
| 10/12/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $68.36 | General |
| Category: Immunology | ||||||
| 10/12/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $65.69 | General |
| Category: Immunology | ||||||
| 10/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $8.27 | General |
| 10/02/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $21.10 | General |
| 09/27/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $49.08 | General |
| 09/18/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Neurology | ||||||
| 09/10/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,387.50 | General |
| Category: Immunology | ||||||
| 09/10/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Travel and Lodging | In-kind items and services | $1,164.55 | General |
| Category: Immunology | ||||||
| 09/10/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Travel and Lodging | In-kind items and services | $546.85 | General |
| Category: Immunology | ||||||
| 09/10/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Travel and Lodging | In-kind items and services | $349.17 | General |
| Category: Immunology | ||||||
| 09/10/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $130.16 | General |
| Category: Immunology | ||||||
| 09/09/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $5.75 | General |
| 08/29/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,415.00 | General |
| Category: Neurology | ||||||
| 08/22/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $62.33 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 328 | 34,543 | $1.6M | $664,557 |
| 2022 | 7 | 323 | 38,148 | $1.1M | $710,293 |
| 2021 | 5 | 139 | 5,849 | $172,855 | $105,946 |
| 2020 | 3 | 79 | 91 | $16,590 | $7,500 |
Total Patients
869
Total Services
78,631
Medicare Billing
$1.5M
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2323 | Injection, natalizumab, 1 mg | Office | 2023 | 69 | 30,308 | $884,880 | $522,246 | 59.0% |
| J2350 | Injection, ocrelizumab, 1 mg | Office | 2023 | 11 | 3,903 | $614,133 | $128,175 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 101 | $15,950 | $6,998 | 43.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 62 | 100 | $32,000 | $4,544 | 14.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 21 | 24 | $8,010 | $1,210 | 15.1% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 15 | 34 | $3,550 | $588.06 | 16.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $1,300 | $478.31 | 36.8% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 17 | 28 | $980.00 | $247.82 | 25.3% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 14 | 14 | $420.00 | $53.67 | 12.8% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2023 | 16 | 20 | $1,000 | $16.52 | 1.7% |
| J2323 | Injection, natalizumab, 1 mg | Office | 2022 | 79 | 37,817 | $1.0M | $690,162 | 66.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 96 | 110 | $17,300 | $8,981 | 51.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 74 | 137 | $43,960 | $6,787 | 15.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 21 | 21 | $6,500 | $2,388 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 18 | $2,070 | $1,019 | 49.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 15 | 15 | $5,100 | $927.41 | 18.2% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2022 | 22 | 30 | $1,500 | $29.31 | 2.0% |
| J2323 | Injection, natalizumab, 1 mg | Office | 2021 | 16 | 5,700 | $144,525 | $93,844 | 64.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 76 | $11,680 | $6,393 | 54.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 24 | 24 | $7,300 | $3,275 | 44.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 31 | $3,560 | $1,507 | 42.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 15 | 18 | $5,790 | $925.99 | 16.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 43 | 53 | $8,230 | $3,647 | 44.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 22 | 22 | $6,600 | $2,974 | 45.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 16 | $1,760 | $877.80 | 49.9% |
About Dr. Timothy West, MD
Dr. Timothy West, MD is a Neurology healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1861650731.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy West, MD has received a total of $1.0M in payments from pharmaceutical and medical device companies, with $75,034 received in 2024. These payments were reported across 1,211 transactions from 55 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($699,022).
As a Medicare-enrolled provider, West has provided services to 869 Medicare beneficiaries, totaling 78,631 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Salt Lake City, UT
- Active Since 05/28/2008
- Last Updated 07/22/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861650731
Products in Payments
- TYSABRI (Biological) $164,725
- TECFIDERA (Drug) $100,448
- Mavenclad (Drug) $82,487
- VUMERITY (Drug) $77,891
- MAVENCLAD (Drug) $63,331
- GILENYA (Drug) $52,605
- BRIUMVI (Drug) $52,061
- AUBAGIO (Drug) $44,231
- Mavenclad (Biological) $43,883
- Rebif (Biological) $40,600
- COPAXONE (Drug) $40,002
- Non-Covered Product (Drug) $28,644
- MAYZENT (Drug) $15,108
- Tysabri (Biological) $14,203
- FTY720D (Drug) $11,412
- KESIMPTA (Drug) $9,897
- OCREVUS (Biological) $8,425
- NO PRODUCT DISCUSSED (Drug) $8,372
- UPLIZNA (Biological) $7,744
- Vumerity (Drug) $6,750
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Salt Lake City
Stacey Steeves, Md, MD
Neurology — Payments: $735,535
Neurology $735,535
Dr. John Foley, M.d, M.D
Neurology — Payments: $345,032
Neurology $345,032
Dr. Amir Arain, Md, MD
Neurology — Payments: $288,901
Neurology $288,901
Mark Bromberg, M.d.,Ph.d, M.D.,PH.D
Neurology — Payments: $252,027
Neurology $252,027
Lucy Dewitt, Md, MD
Neurology — Payments: $126,769
Neurology $126,769
Dr. Viktoria Kaplan, Md, MD
Neurology — Payments: $93,379
Neurology $93,379